Related Experiment Video
Updated: Jul 13, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Oral mucositis: review of pathogenesis, diagnosis, prevention, and management
Joel J Napenas1, Kishore V Shetty, Charles F Streckfus
1Carolinas Medical Center, Charlotte, North Carolina, USA.
Abstract:
Oral mucositis is a debilitating and morbid condition among cancer patients that affects their quality of life and their overall ability to respond to treatment. The dentist plays an important role in the multidisciplinary health care team for the overall management of this condition. This article summarizes preventive and therapeutic treatment modalities available to dentists, based on the latest literature.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Assessment of the Mouth
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Tonsillitis II: Management
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...